These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 499590)

  • 1. A progressive rise in serum copper levels in women taking oral contraceptives: a potential hazard?
    Rubinfeld Y; Maor Y; Simon D; Modai D
    Fertil Steril; 1979 Nov; 32(5):599-601. PubMed ID: 499590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc and copper nutriture of women taking oral contraceptive agents.
    Vir SC; Love AH
    Am J Clin Nutr; 1981 Aug; 34(8):1479-83. PubMed ID: 6791490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptives and ascorbic acid.
    Rivers JM
    Am J Clin Nutr; 1975 May; 28(5):550-4. PubMed ID: 1093379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between levels of blood lipids, vitamins C, A, and E, serum copper compounds, and urinary excretions of tryptophan metabolites in women taking oral contraceptive therapy.
    Horwitt MK; Harvey CC; Dahm CH
    Am J Clin Nutr; 1975 Apr; 28(4):403-12. PubMed ID: 1119436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum levels of copper, iron, magnesium, calcium and zinc in women with a normal menstrual cycle, under treatment with oral hormonal contraceptives and in pregnancy].
    Hähn N; Paschen K; Haller J
    Arch Gynakol; 1972; 213(2):176-86. PubMed ID: 4678746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of oral contraceptive use on iron and copper concentrations in breast milk.
    Dorea JG; Miazaki ES
    Fertil Steril; 1999 Aug; 72(2):297-301. PubMed ID: 10438999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oral contraceptive agents on copper and zinc balance in young women.
    Crews MG; Taper LJ; Ritchey SJ
    Am J Clin Nutr; 1980 Sep; 33(9):1940-5. PubMed ID: 7416062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum copper and zinc in hormonal contraceptive users.
    Prema K; Ramalakshmi BA; Babu S
    Fertil Steril; 1980 Mar; 33(3):267-71. PubMed ID: 6444895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron stores in users of oral contraceptive agents.
    Frassinelli-Gunderson EP; Margen S; Brown JR
    Am J Clin Nutr; 1985 Apr; 41(4):703-12. PubMed ID: 3984924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A quantitative study of the pregnancy zone protein in sera of woman taking oral contraceptives.
    Damber MG; von Schoultz B; Solheim F; Stigbrand T
    Am J Obstet Gynecol; 1976 Feb; 124(3):289-92. PubMed ID: 55075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in serum copper and ceruloplasmin activity following a long term intake of combined oral contraceptives in Iranian women.
    Kamyab S; Baghdiantz A; Jenati S
    J Endocrinol Invest; 1980; 3(2):173-5. PubMed ID: 7391523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
    Rosing J; Middeldorp S; Curvers J; Christella M; Thomassen LG; Nicolaes GA; Meijers JC; Bouma BN; Büller HR; Prins MH; Tans G
    Lancet; 1999 Dec; 354(9195):2036-40. PubMed ID: 10636369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
    Crook D; Godsland IF; Worthington M; Felton CV; Proudler AJ; Stevenson JC
    Am J Obstet Gynecol; 1993 Nov; 169(5):1183-9. PubMed ID: 8238183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum vitamin A and retinol-binding protein in malnourished women treated with oral contraceptives: effects of estrogen dose and duration of treatment.
    Mohan Ram M; Bamji MS
    Am J Obstet Gynecol; 1979 Oct; 135(4):470-2. PubMed ID: 573554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of fluconazole on circulating ethinyl estradiol levels in women taking oral contraceptives.
    Sinofsky FE; Pasquale SA
    Am J Obstet Gynecol; 1998 Feb; 178(2):300-4. PubMed ID: 9500490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of protein S during the normal menstrual cycle and in women on oral contraceptives low in estrogen.
    Jespersen J; Nielsen MT
    Gynecol Obstet Invest; 1989; 28(2):82-6. PubMed ID: 2529199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of kind of carbohydrate in the diet and use of oral contraceptives on metabolism of young women. I. Blood and urinary lactate, uric acid, and phosphorus.
    Kelsay JL; Behall KM; Moser PB; Prather ES
    Am J Clin Nutr; 1977 Dec; 30(12):2016-22. PubMed ID: 930871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.